OAM
ARIA

Oxford Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Oxford Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,415
Closed -$490K – 1561
2016
Q4 		$490K Sell
39,415
-292,973
-88% -$3.53M 0.02% 590
2016
Q3 		$4.55M Sell
332,388
-426,131
-56% -$4.28M 0.14% 164
2016
Q2 		$5.61M Sell
758,519
-225,922
-23% -$1.7M 0.18% 124
2016
Q1 		$6.29M Buy
984,441
+508,263
+107% +$2.85M 0.18% 123
2015
Q4 		$3.01M Buy
476,178
+180,186
+61% +$1.18M 0.07% 306
2015
Q3 		$1.73M Sell
295,992
-472,570
-61% -$3.64M 0.05% 314
2015
Q2 		$6.36M Buy
+768,562
New +$6.8M 0.17% 133
2013
Q4 		– Sell
-536,211
Closed -$9.87M – 872
2013
Q3 		$9.87M Buy
536,211
+328,091
+158% +$6.37M 0.22% 99
2013
Q2 		$3.64M Buy
+208,120
New +$3.69M 0.1% 339

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Oxford Asset Management's ARIA Position: Q1 2017 in Review

Oxford Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 39,415 shares — an estimated $490K sold.

Oxford Asset Management first reported a position in ARIA in Q2 2013 and held it in 9 quarters. The position peaked at $9.87M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Oxford Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Oxford Asset Management sold 39,415 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $490K.
  • Oxford Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
  • Oxford Asset Management's Ariad Pharmaceuticals Inc position peaked at $9.87M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Oxford Asset Management's 13F filing for Q1 2017, filed 9 May 2017.